Bispecific antibodies are already available for treating multiple myeloma. FDA approval of Regeneron Pharmaceuticals’ new drug, Lynozyfic, comes with dosing flexibility that sets it apart from others in its class. The post FDA Approves Regeneron Multiple Myeloma Drug With Dosing Edge Over J&J and Pfizer Meds appeared first on MedCity News.
[Sponsored] A Data-Driven Guide to Patient Access Success highlights how focusing on data accuracy and relevance can enhance healthcare practice performance. The post A Guide to Boosting Healthcare Practice Performance appeared first on MedCity News.
More than 4 million Highmark commercial members now have access to AppliedVR’s RelieVRx as a covered therapeutic. The post Highmark Covers AppliedVR’s Product for Chronic Low Back Pain appeared first on MedCity News.
This volume explores findings from the KFF-Washington Post Survey of Parents on views of childhood vaccines; how ACIP may have contributed to concerns about hepatitis B and COVID-19 vaccines; recent HHS warnings about alleged links between Tylenol use in pregnancy and autism; and AI-generated deepfakes impersonating doctors to sell products.
The World Health Organization has prequalified Coartem Baby, the first and only antimalarial for babies. Novartis developed this combination drug in partnership with Medicines for Malaria Venture. The post Novartis Antimalarial Clears Key WHO Review to Get the Combo Drug to Babies appeared first on MedCity News.
Virtual nursing delivers results at Hackensack University Medical Center
It had been a rough few months. Cynthia Tompkins was hospitalized in May for osteomyelitis — a bone infection — then spent six weeks in a rehabilitation facility. “It was a struggle,” she said. “I didn’t bounce back too well.” Tompkins returned to her home in San Diego, but she was still taking antibiotics, along…
This budget summary provides an analysis of global health funding amounts provided in the House FY 2026 Labor, Health and Human Services, Education, and Related Agencies (Labor HHS) appropriations bill and accompanying report.
New KFF polling explores the challenges beyond costs that people with insurance face in navigating the health care system. People cite prior authorization review as their top problem by a wide margin, with a third (32%) saying prior authorization requirements are a “major burden.
This interactive tool tracks public opinion on the Affordable Care Act, from the inception of the law to the present. It highlights key moments when views shifted and trends based on party identification, income, age, gender, and race/ethnicity.